Advertisement
  • Targeted Therapy for Early-Stage Lung Cancer?

    A trial of the targeted therapy Tagrisso (osimertinib) for early-stage lung cancer finds that patients who take it go longer without having a cancer recurrence. Whether that should change clinical practice is under discussion.

    by Ashley P. Taylor

  • A Missed Conversation

    Despite national guidelines urging oncologists to bring up risks of infertility posed by cancer treatment, many young cancer patients are never told about these risks or counseled on their fertility preservation options.

    by Marcus A. Banks

  • The Return to Work

    What happens if your workplace reopens before you're ready to return or you're an essential worker? For some people who have been diagnosed with cancer, accommodations may be possible.

    by Jen Tota McGivney

  • Sound Advice

    Summer 2020

    vol 10 | issue 02
    Weight gain during treatment, conversations about sex, and what to know about a loved one's insurance.

  • A Delicate Balance

    Cancer patients with chronic pain and the physicians who treat them strive to address pain while avoiding potential opioid abuse and addiction.

    by Charlotte Huff

  • Forward Look

    Cancer Treatments and Antioxidant Supplements Can Be a Bad Mix

    Christine Ambrosone on what her research shows.

    by Sue Rochman

  • Forward Look

    Here Come the Biosimilars

    As patents expire on biologic drugs, cancer patients get new options.

    by Stephen Ornes

  • Your Cancer Guide

    Not Our First Rodeo

    During the COVID-19 pandemic, cancer survivors can tap into familiar lessons of resiliency.

    by Hester Hill Schnipper

  • Caregiving With Confidence

    The Power of Anger

    Accepting this emotion can be the first step in channeling it for a constructive purpose.

    by Karen J. Bannan

  • Healthy Habits

    One Drink, Too Many?

    Drinking at any level increases cancer risk.

    by Ashley P. Taylor